118 related articles for article (PubMed ID: 38043682)
1. Development and In-Vitro Evaluation of Eugenol-Based Nanostructured Lipid Carriers for Effectual Topical Treatment Against C. albicans.
Chilamakuri SN; Kumar A; Nath AG; Gupta A; Selvaraju S; Basrani S; Jadhav A; Gulbake A
J Pharm Sci; 2024 Mar; 113(3):772-784. PubMed ID: 38043682
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
Tian B; Yan Q; Wang J; Ding C; Sai S
Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
[No Abstract] [Full Text] [Related]
3. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
[TBL] [Abstract][Full Text] [Related]
4. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery.
Ramzan M; Gourion-Arsiquaud S; Hussain A; Gulati JS; Zhang Q; Trehan S; Puri V; Michniak-Kohn B; Kaur IP
Drug Deliv Transl Res; 2022 Jul; 12(7):1659-1683. PubMed ID: 34993923
[TBL] [Abstract][Full Text] [Related]
5. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and
Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models.
Riaz A; Hendricks S; Elbrink K; Guy C; Maes L; Ahmed N; Kiekens F; Khan GM
AAPS PharmSciTech; 2020 Jul; 21(5):185. PubMed ID: 32632542
[TBL] [Abstract][Full Text] [Related]
8. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
9. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
10. Meropenem-Loaded Nanostructured Lipid Carriers For Skin and Soft Tissue Infection Caused by Staphylococcus aureus: Formulation, Design, and Evaluation.
Rajpoot K; Prajapati SK; Malaiya A; Jain R; Jain A
AAPS PharmSciTech; 2022 Aug; 23(7):241. PubMed ID: 36008695
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
13. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
14. Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.
Llorente X; Esteruelas G; Bonilla L; Agudelo MG; Filgaira I; Lopez-Ramajo D; Gong RC; Soler C; Espina M; García ML; Manils J; Pujol M; Sánchez-López E
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175765
[TBL] [Abstract][Full Text] [Related]
15. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
16. Hospital wastewater treatment using eco-friendly eugenol nanostructured lipid carriers: Formulation, optimization, and in vitro study for antibacterial and antioxidant properties.
Shajari M; Ahmadi N; Zamani M; Rostamizadeh K; Shapouri R
Water Environ Res; 2022 Jul; 94(7):e10751. PubMed ID: 35765847
[TBL] [Abstract][Full Text] [Related]
17. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies.
Gurumukhi VC; Bari SB
Drug Deliv Transl Res; 2022 Jul; 12(7):1753-1773. PubMed ID: 34671949
[TBL] [Abstract][Full Text] [Related]
18. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
Rapalli VK; Sharma S; Roy A; Singhvi G
Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis.
Tavakoli N; Taymouri S; Saeidi A; Akbari V
Pharm Dev Technol; 2019 Sep; 24(7):891-901. PubMed ID: 31062987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]